Answers are grounded in this paper and cite their sources.
Community acquired pneumonia (CAP) remains a leading cause of morbidity and mortality, with mortality rates between 5% and 15% in hospitalised patients, rising to up to 30% in patients admitted to the intensive care unit (ICU) [1–3]. The current evidence raises more questions than answers, and does not support routine use of corticosteroids for CAP
No takes yet. Share an insight, caveat, or question.
James D. Chalmers (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: